Blood cancers, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Open
Phase 2
This trial is looking at MK-1026 for blood cancer that has come back or following treatment that has stopped working.
Recruitment start: 27 December 2021
Recruitment end: 31 December 2026
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Elizabeth Phillips
Merck Sharp & Dohme Ltd
Last reviewed: 02 Feb 2026
CRUK internal database number: 18341
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
